U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Merck

Market Cap: US$184.5b

Operates as a healthcare company worldwide.

Johnson & Johnson

Market Cap: US$352.2b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Bristol-Myers Squibb

Market Cap: US$89.8b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Amgen

Market Cap: US$141.0b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Pfizer

Market Cap: US$125.2b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Gilead Sciences

Market Cap: US$122.4b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

AbbVie

Market Cap: US$313.4b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Zoetis

Market Cap: US$69.0b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Qiagen

Market Cap: US$8.9b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Viatris

Market Cap: US$9.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Agilent Technologies

Market Cap: US$31.8b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Eli Lilly

Market Cap: US$642.4b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Perrigo

Market Cap: US$3.6b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Organon

Market Cap: US$2.1b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Royalty Pharma

Market Cap: US$18.2b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Illumina

Market Cap: US$12.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

BioLife Solutions

Market Cap: US$1.0b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$6.3b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Avantor

Market Cap: US$8.8b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Medpace Holdings

Market Cap: US$8.4b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Tempus AI

Market Cap: US$11.2b

Operates as a healthcare technology company.

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

Adaptive Biotechnologies

Market Cap: US$1.4b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Soleno Therapeutics

Market Cap: US$3.7b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

TG Therapeutics

Market Cap: US$4.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Corcept Therapeutics

Market Cap: US$7.5b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Pacira BioSciences

Market Cap: US$1.1b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Vaxcyte

Market Cap: US$3.8b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Biogen

Market Cap: US$17.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Halozyme Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

BioNTech

Market Cap: US$22.1b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Sarepta Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Exelixis

Market Cap: US$12.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

ARS Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Travere Therapeutics

Market Cap: US$1.9b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.